0.0650
+0.0030
+(4.84%)
At close: April 17 at 5:35:02 PM GMT+2
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
2,491
5,241
9,768
10,654
Total Liabilities Net Minority Interest
2,785
6,513
5,266
2,956
Total Equity Gross Minority Interest
-294
-1,272
4,502
7,698
Total Capitalization
-294
-1,272
4,515
7,710
Common Stock Equity
-294
-1,272
4,515
7,710
Capital Lease Obligations
66
179
21
69
Net Tangible Assets
-298
-1,276
4,511
7,706
Working Capital
-399
-1,435
4,427
7,630
Invested Capital
806
2,635
6,934
8,256
Tangible Book Value
-298
-1,276
4,511
7,706
Total Debt
1,166
4,086
2,440
615
Share Issued
23,226.9570
2,573.0990
1,103.6230
697.9350
Ordinary Shares Number
23,178.6730
2,551.8840
1,102.2190
696.8590
Treasury Shares Number
48.2840
21.2150
1.4040
1.0760
12/31/2020 - 9/30/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALVIO.PA Valerio Therapeutics Société anonyme
0.0688
+4.24%
ALINT.PA IntegraGen SA
0.5600
-0.88%
ALNEV.PA Neovacs S.A.
0.0219
-3.52%
TCRT Alaunos Therapeutics, Inc.
2.4800
-7.12%
BSEM BioStem Technologies, Inc.
12.17
-4.40%
PRTG Portage Biotech Inc.
7.84
+16.15%
RXRX Recursion Pharmaceuticals, Inc.
5.50
+3.38%